power 2026-04-19
OpenAI's Drug Discovery AI Is Closed-Access. That Is the Whole Strategy.
GPT-Rosalind can access 50+ scientific databases but researchers cannot see its reasoning, weights, or error analysis. OpenAI is positioning to own the epistemic layer of pharmaceutical discovery.